Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and Antimicrobial Assessment.
Ameeduzzafar, Alruwaili NK, Imam SS, Alotaibi NH, Alhakamy NA, Alharbi KS, Alshehri S, Afzal M, Alenezi SK, Bukhari SNA. Ameeduzzafar, et al. Among authors: imam ss. AAPS PharmSciTech. 2020 Jun 5;21(5):167. doi: 10.1208/s12249-020-01699-9. AAPS PharmSciTech. 2020. PMID: 32504176
Stimulus Responsive Ocular Gentamycin-Ferrying Chitosan Nanoparticles Hydrogel: Formulation Optimization, Ocular Safety and Antibacterial Assessment.
Alruwaili NK, Zafar A, Imam SS, Alharbi KS, Alotaibi NH, Alshehri S, Alhakamy NA, Alzarea AI, Afzal M, Elmowafy M. Alruwaili NK, et al. Among authors: imam ss. Int J Nanomedicine. 2020 Jun 30;15:4717-4737. doi: 10.2147/IJN.S254763. eCollection 2020. Int J Nanomedicine. 2020. Retraction in: Int J Nanomedicine. 2023 Mar 21;18:1363-1364. doi: 10.2147/IJN.S413304 PMID: 32636627 Free PMC article. Retracted.
Formulation of amorphous ternary solid dispersions of dapagliflozin using PEG 6000 and Poloxamer 188: solid-state characterization, ex vivo study, and molecular simulation assessment.
Alruwaili NK, Zafar A, Imam SS, Alharbi KS, Alshehri S, Elsaman T, Alomar FA, Akhtar S, Fahmy UA, Alhakamy NA, Alshammari MS. Alruwaili NK, et al. Among authors: imam ss. Drug Dev Ind Pharm. 2020 Sep;46(9):1458-1467. doi: 10.1080/03639045.2020.1802482. Epub 2020 Aug 5. Drug Dev Ind Pharm. 2020. PMID: 32729728
Formulation of Curcumin-β-cyclodextrin-polyvinylpyrrolidone supramolecular inclusion complex: experimental, molecular docking, and preclinical anti-inflammatory assessment.
Jafar M, Khalid MS, Aldossari MFE, Amir M, Alshaer FI, Adrees FAA, Gilani SJ, Alshehri S, Hassan MZ, Imam SS. Jafar M, et al. Among authors: imam ss. Drug Dev Ind Pharm. 2020 Sep;46(9):1524-1534. doi: 10.1080/03639045.2020.1810268. Epub 2020 Aug 27. Drug Dev Ind Pharm. 2020. PMID: 32808552
157 results